Adma Biologics, Inc. (ADMA) — DEF 14A Filings
All DEF 14A filings from Adma Biologics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
ADMA Biologics Files Definitive Proxy Statement
— Apr 15, 2025 Risk: low
ADMA Biologics, Inc. filed its definitive proxy statement (DEF 14A) on April 15, 2025, for its annual meeting of stockholders. The filing outlines the company's -
ADMA Biologics, Inc. Announces Annual Meeting of Stockholders on June 4, 2024
— Apr 15, 2024 Risk: low
ADMA BIOLOGICS, INC. (ADMA) filed a Proxy Statement (DEF 14A) with the SEC on April 15, 2024. ADMA Biologics, Inc. will hold its Annual Meeting of Stockholders
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX